4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001209191-20-023991
Options or other derivatives
- Chief Executive Officer acquired 696,569 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Seehra Jasbir Chief Executive Officer | 2020-04-07 | Grant or award · Employee Stock Option (right to buy) | +696,569 | 696,569 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…